Sarah Margaret Goodday
1, 2
, MSc, PhD ;
Emma Karlin
2
, MPH ;
Madeleine Sorensen
2
, MPH ;
Robin Yang
2
, MSc ;
Paul Gordon
2
, MA ;
Caresse Opoku
2
, MBS ;
Daniel Vuong
2
, BS ;
Jenee Wilson
2
, MBS ;
Diane McKenzie
2
, MHA ;
Jules Piccotti
3
;
Massimiliano Tavanti
3
, BSc ;
Megan Fitzgerald
4
, PhD ;
Yochai Re'em
4
, MD ;
Hannah Wei
4
, BS ;
Megan Golden
5
, JD ;
Daniel Morgan
5
, BBE, MEng ;
Michele Manion
6
, BS ;
Ricardo Mosquera
7
, MD ;
Tricha Shivas
8
, MBE ;
Elise Hoover
8
, MPH ;
Allison Peck
9
, BS ;
Nathan Peck
9
, MBA, MS ;
Zollie Yavarow
9
, PhD ;
Heidi Bjornson-Pennell
10
, JD ;
Andra Stratton
10
, MS ;
Samali Anova Sahoo
11
, BS ;
Douglas Arbittier
11
, MD, MBA ;
Elizabeth Arbittier
11
, VMD ;
Renee Goff
2
;
Donna Harvin-Graham
2
, MBA ;
Nancy Howard
8
, MS ;
Camille Knudsen
9
, BA, BS ;
Mary Oldham
2
, BSc ;
Stephen Friend
1, 2
, MD, PhD
1
Department of Psychiatry, University of Oxford, Oxford, United Kingdom
2
4YouandMe, New York, NY, United States
3
AgileOps, Siena, Italy
4
Patient-Led Research Collaborative, Calabasis, DC, United States
5
Mission: Cure, New York, NY, United States
6
Primary Ciliary Dyskinesia (PCD) Foundation, Rochester, NY, United States
7
Department of Pediatrics, The University of Texas Health Science Center at Houston, Houston, TX, United States
8
Foundation for Sarcoidosis Research, Chicago, IL, United States
9
Cure VCP Disease Inc., Warner Robins, GA, United States
10
Biohub, San Francisco, CA, United States
11
University of Pennsylvania, Philadelphia, PA, United States